These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26440277)

  • 1. Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer.
    Wang Y; Yang J; Lu YJ
    Lung; 2015 Dec; 193(6):1057. PubMed ID: 26440277
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for Advanced-Stage Non-Small Cell Lung Cancer.
    Du L; Morgensztern D
    Cancer J; 2015; 21(5):366-70. PubMed ID: 26389760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of 14 Studies.
    Lu S; Yu Y; Chen Z; Ye X; Li Z; Niu X
    Lung; 2015 Oct; 193(5):805-14. PubMed ID: 26119960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maintenance therapy for advanced non-small-cell lung cancer].
    Saruwatari K; Yoh K
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):926-31. PubMed ID: 25132023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
    Bunn PA
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5919-20. PubMed ID: 17062660
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintenance therapy: a new treatment paradigm in advanced nonsmall-cell lung cancer.
    Gridelli C
    Curr Opin Oncol; 2013 Mar; 25(2):105-6. PubMed ID: 23385858
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy for advanced non-small-cell lung cancer.
    Walling J
    Respir Med; 1994 Oct; 88(9):649-57. PubMed ID: 7528933
    [No Abstract]   [Full Text] [Related]  

  • 8. Focus on maintenance therapy in non-small-cell lung cancer.
    Tartarone A
    Future Oncol; 2015; 11(2):189-92. PubMed ID: 25591835
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of non-small cell lung cancer.
    Williams CJ
    Br J Cancer; 1989 Jul; 60(1):9-11. PubMed ID: 2553089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Established new drugs in the chemotherapy of non-small-cell lung carcinoma (NSCLC)].
    Serke M
    Dtsch Med Wochenschr; 2000 Feb; 125(8):225. PubMed ID: 10723459
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in chemotherapy for lung cancer.
    Lilenbaum RC
    Curr Opin Pulm Med; 1996 Jul; 2(4):285-9. PubMed ID: 9363153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
    Bergman B
    Lakartidningen; 1997 Apr; 94(18):1702, 1707-10. PubMed ID: 9182178
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of PS2 patients with advanced non-small cell lung cancer.
    Cheong KA; Chrystal K; Harper PG
    Int J Clin Pract; 2006 Nov; 60(11):1493-6. PubMed ID: 16911572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of non-small cell lung cancer - where we are?].
    Milanowski J; Szmygin-Milanowska K
    Pneumonol Alergol Pol; 2013; 81(1):55-60. PubMed ID: 23258472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer.
    Shen L; Niu X; Jian H; Xu Y; Yu Y; Lu S
    Lung Cancer; 2017 Sep; 111():43-50. PubMed ID: 28838396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of chemotherapy for patients with advanced non-small cell lung cancer.
    Pennell NA
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS46-50. PubMed ID: 22614966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2003 highlights from: 10th World Congress on Lung Cancer.
    Tyagi F; Lee D
    Clin Lung Cancer; 2003 Sep; 5(2):78-82. PubMed ID: 14614760
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of non-small cell lung cancer: focus on erlotinib. Foreword.
    Cappuzzo F
    Drugs; 2012 Jun; 72 Suppl 1():1-2. PubMed ID: 22712791
    [No Abstract]   [Full Text] [Related]  

  • 20. Second-line erlotinib for non-small-cell lung cancer.
    Lorusso V; Cinieri S
    Lancet Oncol; 2012 Apr; 13(4):e141-2; author reply e142. PubMed ID: 22469123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.